3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Motor Activity
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Neoplasms
3
Pain, Postoperative
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Cognitive Complications
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pathologic Processes
1
Papillomavirus Infections
1
Neuroendocrine Tumors
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Lymphedema
1
Lymphatic Metastasis
1
Liver Diseases
1
Keratosis, Actinic
1
Infections
1
Gastrostomy
1
Fatigue
1
Epstein-Barr Virus Infections
1
Endometrial Neoplasms
1
Emergence Delirium
1
Interventions
dapagliflozin
1
Topotecan
1
Tomography, X-Ray Computed
1
Magnetoencephalography
1
Magnetic Resonance Imaging
1
High-Intensity Interval Training
1
Cyclophosphamide
1
Control Groups
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pediatric Brain Tumor
×
Control Groups
×
Clear all
NCT05740839
2026-02-24
HYPE
Dana-Farber Cancer Institute
Phase NA
Recruiting
30 enrolled